Liezl Gambe

Coinbase has launched pre-IPO trading markets, starting with exposure to SpaceX through a perpetual futures contract tied to the company's private market valuation.

Mayne Pharma Group (ASX:MYX) confirmed the receipt of $14.4 million from Cosette Pharmaceuticals.

Bitmine Immersion Technologies is facing mounting pressure after Ethereum's decline below $1,800 pushed the value of its massive crypto treasury sharply lower.

Megaport (ASX:MP1) completed the institutional component of its fully underwritten $827.3 million entitlement offer.

Nigel Farage’s Reform UK raised $9.4 million from cryptocurrency billionaires Christopher Harborne and Ben Delo in the first quarter of 2026, helping the party outpace both Labour and the Conservatives in fundraising.

Euroz Hartleys Group (ASX:EZL) has responded to recent media speculation regarding the potential sale of its capital markets business.

Guidewire Software (NYSE:GWRE) reported strong financial results for its fiscal third quarter ended April 30, 2026, delivering a 27% year-over-year revenue increase to $372.5 million.

The U.S. Supreme Court delivered a significant victory to the Federal Communications Commission (FCC) on Thursday, June 4, 2026, ruling that the agency's internal system for imposing financial penalties—known as "forfeiture orders"—does not violate the Seventh Amendment right to a jury trial.

Bitcoin fell sharply over seven days as institutional outflows, leveraged liquidations, geopolitical pressure, and a surprise sale by Strategy weighed on digital asset markets.

Teva Pharmaceutical (NYSE:TEVA) announced the launch of AHZANTIVE (aflibercept), a biosimilar to Eylea, across several major European markets, including France, Germany, Spain, and the Netherlands.